Post by
Bigboyone on Dec 28, 2016 8:48am
Capitol Cube Rates Aralez and its not all good-
Capitol Cube Says we so far, we lack good leadership and a forward real direction despite Adams past record, Profit margins at best, will be slim. Aralez can change that outlook by having a real development plan and building some momentum on top of that, Etc-
Somthing has to be a-miss, as the Dow aproaches 20,000 and we are at $4.60 a share.
I do hope 2017 is a better year for all.
https://www.capitalcube.com/blog/index.php/aralez-pharmaceuticals-inc-value-analysis-nasdaqarlz-december-27-2016/
Comment by
GoldenDilemma on Dec 29, 2016 10:03am
You're supposedly an ex-broker and are posting a Capital Cube article.